These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2002797)

  • 1. DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment.
    Gonzalez FJ; Crespi CL; Gelboin HV
    Mutat Res; 1991 Mar; 247(1):113-27. PubMed ID: 2002797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gene knockout mice in understanding the mechanisms of chemical toxicity and carcinogenesis.
    Gonzalez FJ; Kimura S
    Cancer Lett; 1999 Sep; 143(2):199-204. PubMed ID: 10503904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of procarcinogens by human cytochrome P450 enzymes.
    Guengerich FP; Shimada T
    Mutat Res; 1998 May; 400(1-2):201-13. PubMed ID: 9685642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays.
    Shimada T; Gillam EM; Sandhu P; Guo Z; Tukey RH; Guengerich FP
    Carcinogenesis; 1994 Nov; 15(11):2523-9. PubMed ID: 7955101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice.
    Gonzalez FJ; Kimura S
    Mutat Res; 2001 Jun; 477(1-2):79-87. PubMed ID: 11376689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.
    Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV
    Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of promutagens by human cDNA-expressed cytochrome P450s.
    Gonzalez FJ; Aoyama T; Gelboin HV
    Prog Clin Biol Res; 1990; 340B():77-86. PubMed ID: 2392453
    [No Abstract]   [Full Text] [Related]  

  • 8. Human cDNA-expressed cytochrome P450 IA2: mutagen activation and substrate specificity.
    Aoyama T; Gonzalez FJ; Gelboin HV
    Mol Carcinog; 1989; 2(4):192-8. PubMed ID: 2803520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
    Lewis DF; Ioannides C; Parke DV
    Environ Health Perspect; 1998 Oct; 106(10):633-41. PubMed ID: 9755138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes. Role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver.
    Shimada T; Okuda Y
    Biochem Pharmacol; 1988 Feb; 37(3):459-65. PubMed ID: 3337745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
    Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
    Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical carcinogenesis, mutagenesis, and teratogenesis.
    O'Brien PJ; Hales BF; Josephy PD; Castonguay A; Yamazoe Y; Guengerich FP
    Can J Physiol Pharmacol; 1996 May; 74(5):565-71. PubMed ID: 8884021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of bioactivation of chemical carcinogens.
    Glatt HR
    Biochem Soc Trans; 2000 Feb; 28(2):1-6. PubMed ID: 10816089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer.
    Nedelcheva V; Gut I
    Xenobiotica; 1994 Dec; 24(12):1151-75. PubMed ID: 7771104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test.
    Masson HA; Ioannides C; Gorrod JW; Gibson GG
    Carcinogenesis; 1983 Dec; 4(12):1583-6. PubMed ID: 6418403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined COMPACT and HazardExpert study of 40 chemicals for which information on mutagenicity and carcinogenicity is known, including the results of human epidemiological studies.
    Lewis DF; Ioannides C; Parke DV
    Hum Exp Toxicol; 1998 Oct; 17(10):577-86. PubMed ID: 9821022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.